---
title: "Acrobiosystems Co.,Ltd. (301080.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301080.SZ.md"
symbol: "301080.SZ"
name: "Acrobiosystems Co.,Ltd."
industry: "Biotechnology"
datetime: "2026-05-21T07:38:10.262Z"
locales:
  - [en](https://longbridge.com/en/quote/301080.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301080.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301080.SZ.md)
---

# Acrobiosystems Co.,Ltd. (301080.SZ)

## Company Overview

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | CN Market |
| Website | [www.acrobiosystems.cn](https://www.acrobiosystems.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: B (0.29)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 81 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 29.42% |  |
| Net Profit YoY | 28.05% |  |
| P/B Ratio | 2.72 |  |
| Dividend Ratio | 0.65% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 7333334941.49 |  |
| Revenue | 885507727.47 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.43% | C |
| Profit Margin | 19.30% | A |
| Gross Margin | 90.35% | A |
| Revenue YoY | 29.42% | A |
| Net Profit YoY | 28.05% | B |
| Total Assets YoY | 5.49% | C |
| Net Assets YoY | 3.29% | C |
| Cash Flow Margin | 211.52% | B |
| OCF YoY | 29.42% | A |
| Turnover | 0.30 | D |
| Gearing Ratio | 9.55% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Acrobiosystems Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "29.42%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "28.05%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.72",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.65%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "7333334941.49",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "885507727.47",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.43%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "19.30%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "90.35%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "29.42%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "28.05%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "5.49%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "3.29%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "211.52%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "29.42%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.30",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "9.55%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 42.91 | 17/81 | 65.36 | 54.69 | 45.94 |
| PB | 2.72 | 40/81 | 3.80 | 3.36 | 2.78 |
| PS (TTM) | 8.28 | 38/81 | 13.35 | 11.83 | 9.40 |
| Dividend Yield | 0.65% | 30/81 | 0.94% | 0.84% | 0.63% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Sunshine Guojian Pharmaceutical (688336.SH) | A | A | B | A | B | A |
| 02 | AMOYTOP (688278.SH) | A | A | A | A | B | A |
| 03 | BeOne Medicines (688235.SH) | B | A | B | C | A | B |
| 04 | RemeGen (688331.SH) | A | A | C | C | B | B |
| 05 | InnoCare Pharma (688428.SH) | B | A | D | B | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-17T16:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 83% |
| Overweight | 1 | 17% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 42.80 |
| Highest Target | 80.00 |
| Lowest Target | 64.05 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/301080.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/301080.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/301080.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/301080.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**